Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT
Multiple myeloma (MM) is a heterogenous malignant disease. Novel agents including bispecific antibodies and chimeric antigen receptor (CAR) T cells have improved response rates and patient outcome, but the majority of patients ultimately still relapse. High dose chemotherapy followed by autologous h...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
30 July 2025
|
| In: |
Bone marrow transplantation
Year: 2025, Jahrgang: 60, Heft: 10, Pages: 1361-1368 |
| ISSN: | 1476-5365 |
| DOI: | 10.1038/s41409-025-02675-2 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41409-025-02675-2 Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41409-025-02675-2 
|
| Verfasserangaben: | Simona Iacobelli, Stefan Schönland, Linda Koster, Didier Blaise, Emma Nicholson, A. E. C. Broers, Patrice Chevallier, Péter Reményi, František Folber, John G. Gribben, Erfan Nur, Neil Rabin, Matthew Collin, Tobias Gedde-Dahl, Katharine Bailey, Paul Ferguson, Matthias Stelljes, Adrian Bloor, Meral Beksac, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J. Hayden, Ibrahim Yakoub-Agha, Donal P. McLornan and Nicolaus Kröger |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1948521652 | ||
| 003 | DE-627 | ||
| 005 | 20260112184923.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260112s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41409-025-02675-2 |2 doi | |
| 035 | |a (DE-627)1948521652 | ||
| 035 | |a (DE-599)KXP1948521652 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Iacobelli, Simona |e VerfasserIn |0 (DE-588)1137217367 |0 (DE-627)894204041 |0 (DE-576)491164025 |4 aut | |
| 245 | 1 | 0 | |a Outcomes following different upfront stem cell transplantation strategies for multiple myeloma |b a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT |c Simona Iacobelli, Stefan Schönland, Linda Koster, Didier Blaise, Emma Nicholson, A. E. C. Broers, Patrice Chevallier, Péter Reményi, František Folber, John G. Gribben, Erfan Nur, Neil Rabin, Matthew Collin, Tobias Gedde-Dahl, Katharine Bailey, Paul Ferguson, Matthias Stelljes, Adrian Bloor, Meral Beksac, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J. Hayden, Ibrahim Yakoub-Agha, Donal P. McLornan and Nicolaus Kröger |
| 264 | 1 | |c 30 July 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.01.2026 | ||
| 520 | |a Multiple myeloma (MM) is a heterogenous malignant disease. Novel agents including bispecific antibodies and chimeric antigen receptor (CAR) T cells have improved response rates and patient outcome, but the majority of patients ultimately still relapse. High dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto-HCT) remains standard care of treatment for transplant-eligible patients. While single auto-HCT is commonly used, a planned tandem auto-HCT or auto-allo approach remains controversial, based on conflicting results from clinical trials. Here we compared the outcome of 24,936 MM patients aged between 20 and 65 years who underwent first auto-HCT during 2002-2015, reported to the EBMT registry, of whom 3683 and 878 got tandem auto-HCT and auto-allo-HCT respectively. We used non-standard statistical approaches to account for time-dependence of treatments and of their effects, including models with multiple timescales and dynamic prediction. Differences were reported by graphs of hazard functions, hazard ratios and conditional probabilities over time. For both OS and PFS, there was a limited but persistent advantage for the tandem auto-HCT group compared to single auto-HCT, and a clear advantage for the auto-allo-HCT group over both other strategies in the longer term, albeit at the cost of higher early mortality. | ||
| 650 | 4 | |a Myeloma | |
| 650 | 4 | |a Stem-cell research | |
| 700 | 1 | |a Schönland, Stefan |d 1969- |e VerfasserIn |0 (DE-588)122405226 |0 (DE-627)705896137 |0 (DE-576)293255792 |4 aut | |
| 700 | 1 | |a Koster, Linda |e VerfasserIn |4 aut | |
| 700 | 1 | |a Blaise, Didier |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nicholson, Emma |e VerfasserIn |4 aut | |
| 700 | 1 | |a Broers, A. E. C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chevallier, Patrice |e VerfasserIn |4 aut | |
| 700 | 1 | |a Reményi, Péter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Folber, František |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gribben, John G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nur, Erfan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rabin, Neil |e VerfasserIn |4 aut | |
| 700 | 1 | |a Collin, Matthew |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gedde-Dahl, Tobias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bailey, Katharine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ferguson, Paul |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stelljes, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bloor, Adrian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Beksac, Meral |e VerfasserIn |4 aut | |
| 700 | 1 | |a Drozd-Sokolowska, Joanna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Raj, Kavita |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hayden, Patrick J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Yakoub-Agha, Ibrahim |e VerfasserIn |4 aut | |
| 700 | 1 | |a McLornan, Donal P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kröger, Nicolaus |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bone marrow transplantation |d London : Springer Nature, 1997 |g 60(2025), 10 vom: Okt., Seite 1361-1368 |h Online-Ressource |w (DE-627)320433366 |w (DE-600)2004030-1 |w (DE-576)091012996 |x 1476-5365 |7 nnas |a Outcomes following different upfront stem cell transplantation strategies for multiple myeloma a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT |
| 773 | 1 | 8 | |g volume:60 |g year:2025 |g number:10 |g month:10 |g pages:1361-1368 |g extent:8 |a Outcomes following different upfront stem cell transplantation strategies for multiple myeloma a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41409-025-02675-2 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41409-025-02675-2 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260112 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 122405226 |a Schönland, Stefan |m 122405226:Schönland, Stefan |d 910000 |d 910100 |d 50000 |e 910000PS122405226 |e 910100PS122405226 |e 50000PS122405226 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 2 | ||
| 999 | |a KXP-PPN1948521652 |e 4845400995 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"given":"Simona","role":"aut","display":"Iacobelli, Simona","family":"Iacobelli"},{"family":"Schönland","display":"Schönland, Stefan","given":"Stefan","role":"aut"},{"display":"Koster, Linda","family":"Koster","given":"Linda","role":"aut"},{"display":"Blaise, Didier","family":"Blaise","role":"aut","given":"Didier"},{"family":"Nicholson","display":"Nicholson, Emma","role":"aut","given":"Emma"},{"display":"Broers, A. E. C.","family":"Broers","role":"aut","given":"A. E. C."},{"display":"Chevallier, Patrice","family":"Chevallier","role":"aut","given":"Patrice"},{"role":"aut","given":"Péter","family":"Reményi","display":"Reményi, Péter"},{"role":"aut","given":"František","display":"Folber, František","family":"Folber"},{"family":"Gribben","display":"Gribben, John G.","role":"aut","given":"John G."},{"given":"Erfan","role":"aut","display":"Nur, Erfan","family":"Nur"},{"role":"aut","given":"Neil","display":"Rabin, Neil","family":"Rabin"},{"family":"Collin","display":"Collin, Matthew","given":"Matthew","role":"aut"},{"role":"aut","given":"Tobias","display":"Gedde-Dahl, Tobias","family":"Gedde-Dahl"},{"display":"Bailey, Katharine","family":"Bailey","role":"aut","given":"Katharine"},{"role":"aut","given":"Paul","family":"Ferguson","display":"Ferguson, Paul"},{"given":"Matthias","role":"aut","display":"Stelljes, Matthias","family":"Stelljes"},{"display":"Bloor, Adrian","family":"Bloor","role":"aut","given":"Adrian"},{"role":"aut","given":"Meral","family":"Beksac","display":"Beksac, Meral"},{"role":"aut","given":"Joanna","family":"Drozd-Sokolowska","display":"Drozd-Sokolowska, Joanna"},{"display":"Raj, Kavita","family":"Raj","given":"Kavita","role":"aut"},{"role":"aut","given":"Patrick J.","family":"Hayden","display":"Hayden, Patrick J."},{"family":"Yakoub-Agha","display":"Yakoub-Agha, Ibrahim","role":"aut","given":"Ibrahim"},{"display":"McLornan, Donal P.","family":"McLornan","role":"aut","given":"Donal P."},{"role":"aut","given":"Nicolaus","display":"Kröger, Nicolaus","family":"Kröger"}],"id":{"doi":["10.1038/s41409-025-02675-2"],"eki":["1948521652"]},"physDesc":[{"noteIll":"Illustrationen","extent":"8 S."}],"name":{"displayForm":["Simona Iacobelli, Stefan Schönland, Linda Koster, Didier Blaise, Emma Nicholson, A. E. C. Broers, Patrice Chevallier, Péter Reményi, František Folber, John G. Gribben, Erfan Nur, Neil Rabin, Matthew Collin, Tobias Gedde-Dahl, Katharine Bailey, Paul Ferguson, Matthias Stelljes, Adrian Bloor, Meral Beksac, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J. Hayden, Ibrahim Yakoub-Agha, Donal P. McLornan and Nicolaus Kröger"]},"recId":"1948521652","relHost":[{"title":[{"title":"Bone marrow transplantation","title_sort":"Bone marrow transplantation"}],"note":["Gesehen am 17.01.25"],"origin":[{"dateIssuedDisp":"1997-","publisher":"Springer Nature ; Macmillan ; Nature Publishing Group","dateIssuedKey":"1997","publisherPlace":"London ; Basingstoke ; London"}],"pubHistory":["Nachgewiesen 19.1997 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Outcomes following different upfront stem cell transplantation strategies for multiple myeloma a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMTBone marrow transplantation","physDesc":[{"extent":"Online-Ressource"}],"recId":"320433366","id":{"issn":["1476-5365"],"zdb":["2004030-1"],"eki":["320433366"]},"language":["eng"],"part":{"volume":"60","extent":"8","year":"2025","pages":"1361-1368","issue":"10","text":"60(2025), 10 vom: Okt., Seite 1361-1368"}}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title_sort":"Outcomes following different upfront stem cell transplantation strategies for multiple myeloma","subtitle":"a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT","title":"Outcomes following different upfront stem cell transplantation strategies for multiple myeloma"}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"30 July 2025"}],"note":["Gesehen am 12.01.2026"]} | ||
| SRT | |a IACOBELLISOUTCOMESFO3020 | ||